Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study

Post author:admin
Post published:July 14, 2026
Post category:uncategorized

A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Housing affordability for new mothers may help stave off postpartum depression

Dual-functional Qx-D scaffolds hold immense promise for treating infected bone defects

Tooth and gum problems common among teenage footballers in England

Helpful Links

Subscribe To Us